This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Weisheng Xu: Innovator in Cancer Treatment
Introduction
Weisheng Xu is a notable inventor based in Forest Hills, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on developing effective therapies for patients afflicted with cancer.
Latest Patents
Weisheng Xu holds a patent for "HDAC 6 inhibitor-based methods for treating cancer." This invention provides methods for treating a subject afflicted with cancer by concurrently administering an HDAC 6-selective inhibitor along with a suitable cytotoxic agent such as SAHA, doxorubicin, or etoposide. Additionally, the patent outlines methods for inducing the death of transformed cells, including cancer cells, by contacting them with the same combination of agents.
Career Highlights
Weisheng Xu is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts his research. His work has been instrumental in advancing the understanding and treatment of cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Weisheng Xu collaborates with esteemed colleagues, including Paul A. Marks and Mandana Namdar. These partnerships enhance the research efforts and contribute to the development of innovative cancer therapies.
Conclusion
Weisheng Xu's contributions to cancer treatment through his patented methods highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile